Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company Snapshot
Ajanta Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
532331
INE031B01049
282.5572901
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
AJANTPHARM
43
36719.79
EPS(TTM)
Face Value(
)
Div & Yield %:
68.36
2
1.75
BSE
NSE
As on: Nov 22, 2024 01:26 AM
Last Price(
)
Net Change (%)
Volume (Nos)
P / E
2,950.55
10.90
2730
43.00
Chart
|
|
|
|
Stock Price Details
Open Price(
)
2,900.05
Best Buy (
)
0
Best Sell (
)
0
Buy Quantity (Nos)
0
Sell Quantity (Nos)
0
Today's High (
)
2,964.00
Today's Low (
)
2,900.05
52-Week High (
)
3485.75
152-Week Low (
)
1852.55
Market Statistics
Div & Yield %
1.75
Eps
68.36
Book Value
282.5572901
Market Cap (
.Cr)
36,719.79
Face Value
2
Market Lot
1
AGM Date
Jul
Book Closure Date
ISIN No.
INE031B01049
News
Ajanta Pharma Ltd gains for third straight session
Ajanta Pharma Ltd down for fifth straight session
Ajanta Pharma Ltd spurts 2.75%, rises for third straight session
Ajanta Pharma gains after Q2 PAT jumps 11% YoY to Rs 216 cr; declares dividend of Rs 28/ share
Ajanta Pharma Ltd - Ajanta Pharma Limited - Outcome of Board Meeting
Board of Ajanta Pharma recommends First Interim Dividend
Ajanta Pharma fixes record date for 1st Interim Dividend
Ajanta Pharma consolidated net profit rises 10.84% in the September 2024 quarter
Ajanta Pharma Ltd - Ajanta Pharma Limited - Dividend
Ajanta Pharma Ltd - Ajanta Pharma Limited - Record Date
More
Corporate Details
Incoporation Year : 1979
Chairman : Mannalal B Agrawal
Bussiness Group : Indian Private
Registered Office
Ajanta Pharma Ltd
Ajanta House,
Charkop Kandivli (W),
Mumbai,
Maharashtra-400067
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-66061000/1204/1203
Fax:91-22-66061200/1300
Fax:91-22-66317458
E-Mail :
info@ajantapharma.com; investorgrievance@ajantapha
URL :
http://www.ajantapharma.com
Exchange Information
Bombay Stock Exchange
National Stock Exchange
Other Listed Exchanges
BSE 500
BSE HC
BSE Midcap
CNX 500
CNX Pharma
BSE
Kolkata
Chennai
Ahmedabad
Delhi
Kochi